美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco S&P 500 Equal Weight Health Care ETF

36.78

+0.07500.20%

成交量：17.77萬

成交額：654.35萬

市值：8.49億

市盈率：- -

高：37.05

開：36.69

低：36.66

收：36.70

52周最高：38.19

52周最低：28.26

股本：2,309.00萬

流通股本：2,309.00萬

量比：1.91

換手率：0.77%

股息：0.23

股息率：0.63%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證

東方生物：獲得多項境外醫療器械註冊證

九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證

麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂

港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序

【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善

深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行

告別跑腿！虹口優撫對象醫療補助實現「免申即享」

118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖

減重版司美格魯肽在中國獲批脂肪肝適應證，影響多大？

透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理

賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告

市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。

美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D

百事(PEP)拓展冷藏生鮮等新品類應對GLP-1藥物帶來消費行為變化

邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗

中信建投：醫療器械業績持續改善醫療服務收入平穩增長

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/RSPH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.775,"timestamp":1789588800000,"preClose":36.7,"halted":0,"volume":177678,"delay":0,"changeRate":0.002043596730245115,"floatShares":23090000,"shares":23090000,"eps":0,"marketStatus":"盤前交易","change":0.075,"latestTime":"09-17 06:56:53 EDT","open":36.69,"high":37.05,"low":36.66,"amount":6543534.267899999,"amplitude":0.010627,"askPrice":44.5,"askSize":100,"bidPrice":14.79,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":36.775,"sharesOutstanding":23410000,"nav":36.6802,"aum":849146630,"dividendRate":0.006279,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.775,"preClose":36.775,"latestTime":"19:30 EDT","volume":16,"amount":588.355,"timestamp":1789601405974,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9058314747695424,"impliedVol":0.0046,"impliedVolPercentile":0.016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23090000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.9058314747695424,"shares":23090000,"dividePrice":0.2309,"high":37.05,"amplitude":0.010627,"preClose":36.7,"low":36.66,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.775,"eps":0,"divideRate":0.006279,"volume":177678,"delay":0,"ttmEps":0,"open":36.69,"prevYearClose":31.85,"prevWeekClose":36.08,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.3,"twentyDayClose":36,"sixtyDayClose":31.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525651","title":"貝泰妮：注射用透明質酸鈉溶液獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525651?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","RSPH","IEIH","MEDX","HART","LGHT","GDOC","PTH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666230575","title":"東方生物：獲得多項境外醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666230575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666230575?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:05","pubTimestamp":1789121126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","RSPH","AGNG","LGHT","LNGR","PTH","MDEV","HART","GDOC","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544799","title":"九強生物：取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544799?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:50","pubTimestamp":1789113020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","HART","AGNG","IEIH","MDEV","RSPH","LNGR","LGHT","GDOC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市：併購拼出的醫療器械版圖，暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日，麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露，上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田，即将站上港股资本市场。对于麦科田而言，如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机，将决定它能否从并购拼凑的企业，蜕变为具备内生竞争力的医疗器械公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1583","HART","LNGR","XMMO","RSPH","BK1100","BK1574","GDOC","LGHT","CALF","BK4585","IEIH","PTH","AGNG","02041","KCE","BK4588","MDEV","MEDX","159883","MYLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517543?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上，先健科技发布公告，于2026年9月9日，本公司收到国家药品监督管理局的正式书面通知，确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1600","BK1100","159883","MEDX","PTH","RSPH","MDEV","IEIH","VXUS","BK4588","GDOC","HART","KCAI","01302","BK1583","09996","AGNG","LGHT","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235","00853","BK1502","BK1617","KCE","02190","RSPH","HART","PTH","00241","BK1571","BK1515","BK1610","BK1222","BK1591","601066","BK1142","BK1583","HK0000165453.HKD","09996","LU0173614495.USD","BK0276","BK1593","01302","BK1584","LU0287142896.SGD","BK1587","BK1615","MDEV","02252","BK1574","BK1600","AGNG","GDOC","BK1589","LNGR","BK1100","BK1501","LGHT","BK1161","01066","159883","IEIH","06826","BK1247","MEDX","BK1189","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港攜手拓全球藥械市場，2026深圳國際高性能醫療器械展舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1582","BK1574","159883","HART","IEIH","PTH","LU1152091754.HKD","RSPH","BK1583","MEDX","MDEV","BK1507","AGNG","LU0880133367.SGD","LNGR","BK1185","GDOC","00152","BK1100","09996","LU1152091168.USD","LU0067412154.USD","SG9999003461.SGD","LGHT","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560676","title":"告別跑腿！虹口優撫對象醫療補助實現「免申即享」","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560676","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":"街道工作人员向前来咨询的残疾退役军人老王介绍。随后老王在街道工作人员的指导下，完成《告知承诺书》签署。作为全市试点，优抚对象医疗补助在虹口区率先实现“免申即享”。记者了解到，优抚对象就诊后，区退役军人事务部门在扣除各类救助、互助及减负金额后，按规定发放医疗补助。优抚对象还能通过“随申办市民云”APP等渠道查询补助明细与发放进度，实现补助申领“零申请、零材料、零跑动”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-10/doc-inirixkn8584730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348723411.USD","HUM","LU0417517546.SGD","RSPH","BK4588","LU0238689110.USD","LU1093756325.SGD","LU0320765489.SGD","SG9999014013.SGD","BK4533","FXH","SG9999014021.USD","BK4566","LU0211331839.USD","LU0170899867.USD","SG9999014005.SGD","IHF","LU0208291251.USD","LU0070302665.USD","LU0266013472.USD","BK4585","BK4154","LU1093756168.USD","LU0390134368.USD","LU1983260115.SGD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出，未来几年全球MNC将迎来史上最大专利悬崖，有118种生物制剂将会失去相应的专利保护，涉及2340亿美元市场。然而，目前这118款即将到期分子中，只有极少数在火热开发，大量缺口有待生物类似药填补。目前来说，创新药出海还没办法完成这个闭环，但生物类似药作为先头部队做出海试验，企业风险和获益会更高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["FXH","PBPH","PJP","IHE","TMED","TRUH","BBP","159839","RSPH","MEDI","APXH","BME","JDOC","IYH","BBH","PPH","GSKH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666655248","title":"減重版司美格魯肽在中國獲批脂肪肝適應證，影響多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666655248","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666655248?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 12:00","pubTimestamp":1789012800,"startTime":"0","endTime":"0","summary":"诺和诺德将中国减肥药的竞争正式拉到了脂肪肝领域。9月10日，澎湃新闻记者从诺和诺德获悉，减重版司美格鲁肽注射液（商品名：诺和盈）的代谢相关脂肪性肝炎（MASH）适应证上市申请获得中国国家药品监督管理局（NMPA）批准，适用于治疗代谢相关脂肪性肝炎（MASH）伴中重度肝纤维化（符合F2-F3期纤维化）的非肝硬化成人患者，成为首个且唯一获批用于治疗MASH的GLP-1RA类药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609103870407810.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609103870407810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","LU0149534421.HKD","LU2097828557.USD","LU2242644610.SGD","JDOC","LU0326950275.SGD","NVOX","NVOH","MEDI","BK1161","RSPH","LU2488822045.USD","LU2097828474.EUR","BK1589","LU1831875114.USD","LU0455707207.USD","LU2097828805.USD","LU2097828714.EUR","LU0607220059.USD","KURE","LU1188198961.HKD","HK0000165453.HKD","LU1969619763.USD","BK1583","THNR","LU2097828631.EUR","NVOC","LU0244354667.USD","01801","LU0463099449.HKD","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理，产品名称：四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK0046","BK0042","300642","09996","MEDX","BK0239","BK1583","IEIH","HART","LGHT","LNGR","PTH","RSPH","BK1574","159883","GDOC","MDEV","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582190","title":"賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582190","media":"同花顺","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582190?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:39","pubTimestamp":1788950340,"startTime":"0","endTime":"0","summary":"    证券日报网讯9月9日，赛诺医疗发布公告称，公司计划于2026年9月17日15：00-17：00参加上海证券交易所组织的科创板2026年半年度医疗器械及医疗设备行业集体业绩说明 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0251","IEIH","BK1100","IHI","GDOC","BK4588","688108","RSPH","09996","BK1574","XHE","KSTR","MEDX","MDEV","LGHT","PTH","HART","BK4585","BK1583","LNGR","AGNG","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370679","title":"市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:12","pubTimestamp":1788901933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNA","UYG","AAUM","BK4108","PBPH","CANC","DFMC","IYH","FFSM","IBBQ","PRVT","XLFI","BK4561","PSP","WMG","TBXU","RSPH","IEFN","PEVC","ACTV","BK4571","BK4588","MMID","RFG","VXF","BK4585","GTPE","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666743903","title":"美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D","url":"https://stock-news.laohu8.com/highlight/detail?id=2666743903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666743903?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:20","pubTimestamp":1788888000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4154","LU0211331839.USD","LU0256863811.USD","LU0238689110.USD","LU1093756168.USD","LU1093756325.SGD","UNHW","BK4585","LU0390134368.USD","LU0070302665.USD","LU0320765489.SGD","LU1983260115.SGD","RSPH","UNHU","BK4588","BK4566","FXH","SG9999014005.SGD","UN","LU0266013472.USD","SG9999014013.SGD","LU0208291251.USD","HUM","UNHG","BK4533","IHF","LU0417517546.SGD","LU0170899867.USD","LU0348723411.USD","SG9999014021.USD","IEHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322648","title":"百事(PEP)拓展冷藏生鮮等新品類 應對GLP-1藥物帶來消費行為變化","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322648","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322648?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:52","pubTimestamp":1788864759,"startTime":"0","endTime":"0","summary":"据外媒报道，美国商超生鲜周边板块市场规模达2710亿美元，而百事过往在该领域布局较少，存在较大拓展空间。分析师表示，布局生鲜冷藏品类，有助于百事承接消费趋势，应对消费需求逐步从传统包装零食向外迁移的行业变化。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305808","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE000F7OJYX1.SGD","IE00BBT3K403.USD","LU1162221912.USD","BK4533","BK4588","IE00BLSP4452.SGD","NVOC","IE000BZT7R73.USD","IE0000B7K699.USD","IE000MB6IJN5.SGD","BK4550","BK4585","NVOX","BK4581","IE00BN8TJ469.HKD","LU1244550221.USD","LU1244550577.SGD","LU1929549753.HKD","IE00B3T34201.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1894683348.USD","BK4504","NVOH","THNR","BK4534","BK4566","LU1894683264.USD","MEDI","IE000WAW04H5.SGD","PEP","LU0098860793.USD","LU1244550494.USD","IE000SO60NU8.SGD","RSPH","FTXG","JDOC","BK4177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332349","title":"邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:14","pubTimestamp":1788855283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IEIH","PTH","GDOC","HART","IBBQ","LGHT","MDTX","MDEV","MEDX","PSYK","AGNG","RSPH","IBBJ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665434161","title":"中信建投：醫療器械業績持續改善 醫療服務收入平穩增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2665434161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665434161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:56","pubTimestamp":1788836160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。IVD：26Q2 IVD板块收入在过去两年来首次恢复正增长，利润端大幅增长。从收入端来看，二季度板块收入仍保持正增长，其中眼科医疗服务公司2025Q2低基数相对较低，但板块今年二季度收入增速相较一季度的增速有所降低，表明消费环境压力仍然存在。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","BK1574","09996","MDEV","MEDX","159883","LGHT","HART","AGNG","LNGR","PTH","RSPH","GDOC","IEIH","BK1583","BK1100","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311633","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":"诺和诺德在声明中指出，这项名为STEP Young的试验所纳入的全部受试者，在整个研究期间均接受了生活方式干预，包括限制热量摄入和增加体育锻炼。诺和诺德首席科学官马丁·霍尔斯特·兰格表示：“STEP Young试验的积极结果令人振奋，我们看好司美格鲁肽在帮助罹患肥胖的儿童方面的潜力——这些儿童除生活方式调整外，尚需药物治疗以更有效地管理其肥胖状况。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["THNR","CURE","FHLC","XLVI","TRUH","NVOX","PJP","PINK","FXH","NVOC","IYH","MEDI","RSPH","NVOH","BGIA","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311616","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311616?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CURE","XLVI","PINK","RSPH","FXH","IYH","BGIA","NBDS","FHLC","MEDI","THNR","TRUH","PJP","NVOC","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}